San Diego, CA -- (SBWIRE) -- 07/22/2015 -- The Shareholders Foundation announces that an investor in shares of QRxPharma Ltd. (ADR) (OTCMKTS:QRXPY, OTCMKTS:QRXPF), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by QRxPharma Ltd. in connection with certain allegedly false and misleading statements made between January 24, 2011 and April 23, 2014.

Investors who purchased a significant amount of shares of QRxPharma Ltd. (ADR) (OTCMKTS:QRXPY, OTCMKTS:QRXPF) have certain options and for certain investors are short and strict deadlines running. Deadline: August 24, 2015. QRxPharma investors should contact the Shareholders Foundation at mail@shareholdersfoundation or call +1(858) 779 - 1554.

According to the complaint the plaintiff alleges on behalf of purchasers of QRxPharma Ltd. (ADR) (OTCMKTS:QRXPY, OTCMKTS:QRXPF) common shares between January 24, 2011 and April 23, 2014, that the defendants violated Federal Securities Laws by issuing allegedly false and misleading public statements and by allegedly omitting material facts concerning the commercial prospects for its experiment drug Moxduo. More specifically, the plaintiff claims that QRxPharma Ltd allegedly failed to disclose to investors that it received a "no agreement letter" from the Food and Drug Administration ("FDA") regarding its Moxduo trials and further misrepresented and concealed other material facts concerning its attempts to get Moxduo approved and that upon the disclosure of an FDA memorandum which denied QRxPharma Ltd's application to get Moxduo approved, the price of QRxPharma Ltd ADRs plummeted over 83% on April 23, 2014.

Those who purchased shares of QRxPharma Ltd. (ADR) (OTCMKTS:QRXPY, OTCMKTS:QRXPF) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com